ASCEPION PHARMACEUTICALS INC has a total of 28 patent applications. Its first patent ever was published in 2010. It filed its patents most often in China, EPO (European Patent Office) and Taiwan. Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are PLETTENBURG OLIVER, NEUROCRINE INC and DUBOIS LAURENT.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 10 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | Taiwan | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Australia | 1 | |
#6 | Brazil | 1 | |
#7 | Canada | 1 | |
#8 | Colombia | 1 | |
#9 | Israel | 1 | |
#10 | India | 1 | |
#11 | Republic of Korea | 1 | |
#12 | Morocco | 1 | |
#13 | Mexico | 1 | |
#14 | Singapore | 1 | |
#15 | Tunisia | 1 | |
#16 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Wang Qishan | 18 |
#2 | Jiang Shan | 18 |
#3 | Kong Ren | 14 |
#4 | Xing Xinglong | 13 |
#5 | Gao Xiaoyong | 6 |
#6 | Hu Tianshun | 4 |
#7 | Xing Xing-Long | 1 |
#8 | Wang Tonggui | 1 |
#9 | Shan Jiang | 1 |
#10 | Qishan Wang | 1 |
Publication | Filing date | Title |
---|---|---|
CN103420895A | Preparation method of 4-aminoindole | |
CN103420892A | Preparation method of 4-fluoroindole | |
CN103420902A | Preparation method of 2-chloro-4-iodo-5-methylpyridine | |
CN103420905A | Synthetic method of 4-bromine-2,6-diaminopyridine | |
CN103421004A | 5-azaindole preparation method | |
CN103420904A | Method for preparing 2,4-diaminopyridine | |
CN103420964A | Tetrahydropyrane-3-formic acid preparation method | |
CN103420998A | Synthesis method of novel oxadiazoles derivative | |
TW201311681A | Deuterium-enriched heterocyclic compounds as kinase inhibitors | |
WO2012028106A1 | Deuterium-enriched heterocyclic compounds as kinase inhibitors | |
TW201209055A | 5,6-bicyclic heteroaryl-containing urea compounds as kinase inhibitors | |
WO2011023081A1 | 5,6-bicyclic heteroaryl-containing urea compounds as kinase inhibitors |